Cardinal Health extends CVS distribution pact to June 2032; reaffirms FY2027 EPS guidance of $12.40-$12.60

CARDINAL HEALTH INC

Binding letter of intent extends Cardinal Health's existing pharmaceutical distribution agreement with CVS Health through June 30, 2032, continuing the current scope of distribution services.
FY2027 non-GAAP EPS guidance reaffirmed at $12.40 to $12.60, which the company said equals 13% to 15% growth.
Long-term non-GAAP EPS growth guidance of 12% to 14% reiterated alongside the renewal.
CEO Jason Hollar cited the 'long-standing partnership with CVS Health'; further updates may come on the Q1 earnings call scheduled for November 5, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.